BiotechWorld

Aurion Biotech Pursues IPO For Cornea Disease Treatments (Pending:AURN)

Donovan Jones
By Donovan Jones
0 Min Read
aurion-biotech-pursues-ipo-for-cornea-disease-treatments-(pending:aurn)
Aurion Biotech Pursues IPO For Cornea Disease Treatments (Pending:AURN)
- Advertisement -
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with investor support. Explore more details here.
Ipswich 0-4 Arsenal: Bukayo Saka injury not serious
The Best Cryptocurrency to Invest in Might Be One You’re Still Overlooking
Here’s Why Investors Must Own At Least 1,000 XRP if They Care About Their Financial Success: Crypto Founder
Revolutionizing Displays: Dual-Mode Electrochemical Devices Merge Light and Color
New Illinois proposal could help evaluate, implement AI technology in schools
Share This Article
Previous Article biotech-stock-roundup:-regn-up-on-q4-results,-vrtx,-axsm-gain-on-drug-approval Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval
Next Article viracta-therapeutics-hits-end-of-the-line,-laying-off-all-workers-and-winding-down Viracta Therapeutics hits end of the line, laying off all workers and winding down

Recent Comments

No comments to show.

You May also Like

rohnert-park-tea-brand-logs-50-years-in-business
World

Rohnert Park tea brand logs 50 years in business

mexican-president-taps-edgar-amador-as-new-finance-chief
FinanceWorld

Mexican president taps Edgar Amador as new finance chief

ns-budget:-reserve-fund,-tax-cuts-amid-us-tariff-threats
CanadaFeatured Canadian News

NS Budget: Reserve Fund, Tax Cuts Amid US Tariff Threats

denis-coderre-out-of-quebec-liberal-leadership-race-after-being-rejected-by-party
CanadaFeatured Canadian News

Denis Coderre out of Quebec Liberal Leadership Race After Being Rejected by Party

Show More